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The MHC-restricted T cell recognition phenomenon remains ofcentral inter-
est in cellularimmunology. Recent functional, biochemical, andmolecular studies
(reviewed in 1-4) provide abundant information concerning distinctive proper-
ties of the clonotypic T cell recognition structures expressed in stage III thymo-
cytes and virtually all major subclasses of mature peripheral T cells. At the
protein level, the T cell antigen receptor was identified as a heterodimeric
glycoprotein comprised of disulfide-linked a and 0 chains. In humans, the a
chain has a molecular mass in the range of 46-49 kD, and is acidic . The (3 chain
appeared to be a smaller glycoprotein with a molecular mass in the range of 38-
43 kD, and has a more variable pI (slightly acidic to basic) (5-7). Furthermore,
cDNAs corresponding to the characterized human and mouse a and 0 chains
were cloned and sequenced (8-13). The genes encoding a and ,Q chains of the T
cell receptor appeared to have striking similarities to immunoglobulin genes in
both sequence and organization (8, 10-19), and are rearranged during T cell
differentiation (9, 11, 12, 14, 15, 17, 20, 21). Although the T cell receptor genes
are closely related to those encoding the immunoglobulin molecules, a clear
difference between the genes encoding the a/(3 T cell receptor and the immu-
noglobulin molecules was observed (reviewed in 4). In addition, a third rear-
ranged gene (y) with properties similar to the a and (3 genes has been recently
characterized (22-24). The cell surface protein produced by this gene remains
unidentified. The T cell antigen receptor is associated on the membrane of
human T cells with the T3 molecular complex (25, 26). The T3 molecular
complex was identified as a structure consisting of two glycosylated proteins of
-28 and 22 kD, and a nonglycosylated hydrophobic protein of 20 kD (27, 28).
Although evidence that favored the possibility of dual recognition of antigen
and the MHC restriction element by the single a/,Q T cell antigen receptor has
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been recently reported (3, 29-31), the mechanisms of MHC-restricted antigen
recognition by T cells have not been clarified.
Considerable work in this laboratory has focused on the biochemical charac-
terization of the a/,S T cell receptor molecule expressed on the cells of patient
(SU) with Sezary syndrome (7, 32-34). SU leukemia cells have been previously
characterized as morphologically typical Sezary leukemia cells. Unlike other T
cell clones (35) and leukemias (7), they are unresponsive to activation by Sepha-
rose-bound anticlonotypic antibody (S511) recognizing the a/(3 T cell receptor
expressed on these cells (7). Normal T cells bearing the S511 molecule have
been identified as a minor subset (^-2%) of resting peripheral blood T cells (32,
33). Previous studies (7) have shown that the S511 heterodimeric molecule is
slightly different from other reported clonotypic structures expressed on various
leukemia clones, having molecular masses of 38 and 43 kD (two chains) and
slightly acidic pls for each chain. Our attempts to further characterize this T cell
receptor molecule on SU cells have led to a surprising observation. The A1 .4
mAb, recognizing an antigenic determinant on the 02 microglobulin (02m)'-free
HLA heavy chain, coprecipitated from SU leukemia cell lysates a molecule of 38
kD. By peptide mappingexperiments, this 38 kD molecule appeared to be similar
but not identical to thea chain of the T cell receptor expressed on the same SU
leukemia cells (34) . We therefore believe that these cells express two related but
distinct molecules: (a) the classical a/,B T cell antigen receptor, and (b) a 02M-
free HLA heavy chain-like molecule (henceforth referred to as #2m-free HLA)
noncovalently associated with a 38 kD ,0 chain-like molecule (the 38/43 kD
heterodimer). We wondered whether this latter structure might be associated
with T3, in a way similar to that of the a/fl T cell receptor, and that such an
association might give a clue to its functional significance.
This paper describes in detail the biochemical features of this # chain-like 38
kD molecule and its association with the #2m-free HLA heavy chain on the
surface of SU leukemia cells. We also present the evidence for an association of
both the a/# T cell receptor and the 38 kD chain with the T3 complex, as shown
by comodulation experiments. The possible significance of this newly described
structure is discussed.
Materials and Methods
Cells.
￿
Cells derived from the peripheral blood of healthy donors and patients with
Sezary syndrome or T cell chronic lymphocytic leukemia were obtained by Ficoll-Hypaque
density centrifugation.
Monoclonal Antibodies.
￿
mAb S511 (IgG2b) reacting with the idiotype-like molecule on
leukemia cellsof patientSU hasbeen describedpreviously (32). The A1 .4 antibody (IgGI)
recognizing an SDS-stable framework determinant expressedon the heavy chain of HLA-
A,B,C molecules was developed in our laboratory using Con A-activated T cells as the
immunogen. This mAb has been used extensively in previous studies of human class I
molecules (36, 37). Other anti-HLA antibodies used in the present study were W6/32
(38), and an mAb (anti-HLA) developed by D. Capra and associates (University of Texas,
Dallas). Anti-human 02m mAb, designated as BBM.1, has been described previously (39).
The Leu-4 antibody was kindly provided by R. L. Evans (Memorial Sloan-Kettering
Cancer Center).
' Abbreviations used in this paper:
￿
2D, two-dimensional ; S2m, 02-microglobulin; endo-F, endogly-
cosidase F; TL, thymus leukemia.460
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Antigenic Modulation In Vitro . 3 x 107 leukemia cells were suspended in regular
medium at a concentration of 10 7 cells/ml . Freshly isolated PBMC from healthy donors
were added to the cell suspension in 50-ml Falcon tubes at a final concentration of20% .
For complete Leu-4/T3 antigen modulation, 150 A1 of Leu-4 antibody supernatant was
added to 1 ml of suspended cells, followed by incubation for 6 h at 37°C and 5% C02 .
Partial modulation of Leu-4/T3 antigen was achieved by adding 100 Al of Leu-4 antibody
three times at 2-h intervals . After 6 h of incubation, all cultures were transferred to a
small Falcon culture flask for an additional 1-h incubation in the same medium . Nonad-
herent cells were then collected, washed three times with PBS, and used for radioiodina-
tion or immunofluorescence staining.
Cytofuorographic Analysis.
￿
This has been described elsewhere (40) . 10' modulated
cells per sample were incubated with a saturating concentration of Leu-4 mAb followed
by staining with fluorescein-conjugated goat anti-mouse IgG . Fluorescence distributions
were determined with a fluorescence-activated cell sorter (FACS IV ; Becton Dickinson
Immunocytometry Systems, Mountain View, CA) .
Radioiodination and Immunoprecipitation .
￿
3 .0-7 .5 x 10 7 cells were radioiodinated using
the lactoperoxidase method with 5-15 mCi of Na ' 25I (Amersham Corp ., Arlington
Heights, IL) and lysed in 2 ml of buffer composed of 0.5% NP-40 plus 1 mM PMSF
(Sigma Chemical Co ., St . Louis, MO) in PBS (pH 8 .3) without Ca2' and Mg" . Before
immunoprecipitation, bovine hemoglobin (Sigma Chemical Co .) was added to the cell
lysates at a final concentration of 1% to reduce nonspecific binding of labeled material to
antibody-coated beads. Immunoprecipitation was carried out by incubation of the labeled
cell lysates with antibody-coated goat anti-mouse IgG agarose beads (Sigma Chemical
Co.) . The material was eluted from the beads with Laemmli sample buffer (41) for
reducing (with 2% 2-ME) and nonreducing SDS-PAGE, or with IEF sample buffer (36)
for two-dimensional (2D) gel electrophoresis .
In sequential immunoprecipitation experiments, a 150-tcl aliquot of labeled cell lysate
was first incubated with an excess amount of W6/32 antibody-coated goat anti-mouse
IgG agarose beads . This step was performed twice, and the absorbed lysate was subjected
to the subsequent clearing step with A1 .4 antibody (three times) followed by precipitation
with 5511 antibody and SDS-PAGE analysis .
Treatment with Endoglycosidase F (Endo-F).
￿
This method was performed as described
elsewhere (37) .
Immunoblotting.
￿
The method ofJohnson et al . (42) was used with minor modifications .
Briefly, 1 .5 x 107 cells were Iysed in 200 ul of Laemmli sample buffer, and insoluble
nuclear material was removed by passage of the lysate through a piece of gauze before
application on an SDS-PAGE slab . Proteins separated on SDS-PAGE were transferred to
a nitrocellulose sheet at 55 V for 2 .5 h .
SDS-PAGE . and 2D Gel Electrophoresis .
￿
SDS-PAGE was performed according to Lae-
mmli (41) on vertical slab gels of 11% acrylamide . The 2D analysis was performed as
described elsewhere (36) . IEF slab gels for first-dimensional resolution of 2D analysis were
constructed with pH 3.5-10 ampholines(LKB Instruments, Gaithersburg, MD) . The slabs
were then cut into strips for the second-dimension resolution by SDS-PAGE .
Chymotryptic Peptide Mapping.
￿
This was done according to Elder et al . (43) . Radioio-
dinated and sequentially immunoprecipitated molecules (Fig . 5) were isolated from slices
of Laemmli slab gels and subjected to chymotrypsin digestion (50 wg/ml of enzyme in 1
ammonium bicarbonate, pH 8.3) for 18 h at 37°C.
Results
The 38 kD Molecule Is Immunoprecipitated withA1 .4 Antibodyfrom Radioiodinated
Sezary Leukemia Cell Lysates. As illustrated in Fig . 1, the S511 mAb precipitated
from radioiodinated cell lysates of the Sezary leukemia patient SU the a/,Q T cell
receptor molecule consisting of two disulfide-linked polypeptide chains with
molecular masses of 43 and 38 kD, respectively (lane 2) . The A1 .4 mAb,
recognizing an SDS-stable framework determinant on the heavy chain of HLA,BUSHKIN ET AL .
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FIGURE 1 .
￿
SDS-PAGE of the a/,B T cell receptor and HLA molecules precipitated from
radioiodinated Sezary leukemia and normal PBL lysates . Reducing conditions, lanes 1-4 :
beads alone, cell lysate of patient SU reacted with S511 antibody, A1 .4 antibody, and PBL
lysate reacted with A 1 .4 antibody . Nonreducing conditions, as in lanes 2 and3 .
precipitated from the same cell lysate a 38 kD molecule similar in mobility to the
,# chain, in addition to the 43 kD heavy HLA chain and its accompanying 02m
(Fig . 1, lane 3) . In contrast, no such 38 kD band was observed in anti-A IA
precipitate from radioiodinated peripheral blood lymphocyte lysate (Fig . 1, lane
4) . SDS-PAGE under nonreducing conditions revealed that this 38 kD molecule
is not disulfide-linked to any other chain, since no higher molecular mass
component similar to the 80 kD T cell receptor was observed in anti-AIA
precipitates (Fig . 1, lanes 5 and 6) . The lack of interchain disulfide bonding with
the 38 kD polypeptide precipitated by the AIA antibody suggested that this
chain was not identical to the # chain of the T cell receptor molecule expressed
on the same cells. Therefore, we decided to determine the molecular mass of
both polypeptides more accurately . The 38 kD bands precipitated by A1 .4 and
S511 antibodies were both excised from the gel (Fig . 1), eluted with Laemmli
sample buffer and resubmitted to SDS-PAGE . This procedure revealed minor
but reproducible differences in the mobility of both 38 kD chains on SDS-PAGE,
the AIA band migrating slightly faster than the S511 /3 chain band (data not
shown) .
14 other T cell leukemias, including 5 patients with Sezary syndrome and 2
with T cell chronic lymphocytic leukemia were further screened for the presence
of a similar 38 kD band in anti-AIA precipitates . A second patient (PR) with
Sezary syndrome was found to express a similar 38 kD molecule . As seen in Fig.
2, the A1 .4 antibody precipitated from the radioiodinated cell lysate of this
patient a 38 kD chain in addition to the HLA heavy chain and 02m (lane 2) . As
in the case of patient SU (not shown), only A 1 .4 antibody was able to precipitate
this 38 kD molecule but not other anti-HLA and anti-02m antibodies (Fig . 2) .
Similarity in IEF Patterns Between the 38 kD chain and the /3 Chain of the T Cell
Receptorfrom the Same Leukemia Cells . We further characterized 5511 and A1 .4
immunoprecipitates from SU leukemia cell lysates by 2-D (IEF-SDS-PAGE) gel
analysis . The 38 kD molecule precipitated with A1 .4 antibody has not only the
same pl as the 0 chain of the T cell receptor precipitated with 5511 antibody
from the same cell lysate, but also has a very similar IEF pattern (Fig . 3) . To
compare the glycosylation of these two 38 kD chains, endo-F digestion was462
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FIGURE 2 .
￿
SDS-PAGE of radioiodinated cell lysate of patient PR with Sezary syndrome
reacted with various anti-HLA and anti-02m antibodies . Lanes 1-5 : beads alone, A1 .4,W6/32,
anti-HLA developed in Dr . D. Capra's laboratory, and BBM.1 .
FIGURE 3 .
￿
2D gel patterns of the a/flT cell receptor precipitated by S511 antibody, and the
38kD and HLAheavy chain molecules precipitated by A1 .4 antibody from the radioiodinated
cell lysate of patientSU . The 43 kD chain of each immunoprecipitate is designated by arrows,
whereas the 38 kD chain is designated by brackets. Only segments of the autoradiographs are
shown .
performed. Treatment of both immunoprecipitates with endo-F, which cleaves
high-mannose and complex N-linked carbohydrates (44) resulted, in both cases,
in the replacement of 38 kD chains by bands migrating at ~34 kD (Fig . 4) .
However, the band corresponding to the deglycosylated 38 kD chain coprecipi-
tated by Al .4 ran as a more diffuse and slightly faster band than the deglycosy-
lated ,0 chain precipitated by S511 . Thus, SDS-PAGE, 2D gel electrophoresis,
and endo-F digestion were unable to clearly distinguish the two 38 kD chains,
although minor differences were suggested by these experiments .
The 43 kD a chain of the T cell receptor and the HLA heavy chain resolved
in the same pI range (Fig . 3) . It appeared, however, that the 43 kD chains from
both precipitates displayed somewhat different IEF patterns, more complex for
the 43 kD chain precipitated by AIA antibody than for that precipitated by
S511 antibody .
The 38 kD Chain and the a//3 T Cell Receptor Are DifferentMolecules as Shown by
Sequential Immunoprecipitation . Similarities, in both molecular mass and IEFBUSHKIN ET AL .
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FIGURE 4 .
￿
SDS-PAGE of A1 .4 and S511 immunoprecipitates digested with endo-F . A, SU
leukemia cell lysate reacted withA 1 .4 andS511 antibodies followed by digestion ofprecipitates
with endo-F as described (37) . The 34 kD bands corresponding to deglycosylated 38 kD chains
are designated by an arrowand a double-arrow bracket. Studies with a and 0 chains of theT
cell receptor isolated fromSDS-PAGE slabs (Y . Bushkin, unpublished data) indicated that the
band migrating at ^-24 kD (lane 4) is nonspecific . B, the same experimental conditions as in A,
except that SU leukemia cells were modulated by excess of Leu-4 antibody before iodination
and immunoprecipitation with A1 .4 antibody . This modulation results in disappearance ofthe
38 kD chain precipitated by A1.4 as described in the text and Fig. 9 .
patterns of the 38 and 43 kD chains precipitated by A1 .4 antibody, to thea and
/3 chains of the T cell receptor precipitated by the S511 antibody from SU
leukemia cell lysates prompted us to examine the structural relationship between
these molecules. In particular, we asked whether these two 38/43 kD molecules
expressed on the same cells were indeed different molecules. Labeled SU cell
lysate was precleared with W6/32 antibody, which recognizes the HLA heavy
chain in association with fl2m (45), and then subjected to sequential immunopre-
cipitations with A1 .4 and S511 antibodies . As seen in Fig . 5, reaction ofW6/32-
precleared SU cell lysate with A1 .4 antibody resulted in precipitation of both 43
and 38 kD chains, but not 02m (lane 3) . Since preclearing with W6/32 antibody
completely depleted the cell lysate of02m-associated HLA heavy chains precipi-
tated by W6/32 (lane 2), the 43 kD band seen in the A1 .4 precipitate (lane 3)
may represent (02m-free HLA . The intensity of the 43 kD band precipitated by
A1 .4 was strongly reduced by preclearing with W6/32 as expected, since A1 .4
also precipitates 02m-associated HLA heavy chains (Figs . 1 and 2) . We next
reacted sequentially the W6/32- and A1 .4-precleared SU cell lysate with A1 .4
(Fig . 5, lane 4) or S5 I I antibody (lane 5) . The intensity of labeled a and a chains
of the T cell receptor precipitated by 5511 antibody from this precleared SU
cell lysate (Fig . 5, lane 5) appeared to be identical to that precipitated from
untreated lysate (lane 6) . Likewise, preclearing with S511 antibody did not
decrease the intensity of the two bands precipitated by A1 .4 antibody (data not
shown) . These results provided clear evidence that the 43 and 38 kD chains
precipitated by A1 .4 antibody from SU cell lysates, and the a/0T cell receptor
expressed on the same cells are different molecules.
Coprecipitation of both the 43 and 38 kD chains by A1 .4 is probably due to a
noncovalent association, since the AIA antibody recognizes only the 43 kD
chain, as determined by immunoblotting experiments (Fig . 6) . Here it was shown464
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FIGURE 5.
￿
SDS-PAGE of sequential immunoprecipitation of radioiodinated SU leukemia cell
lysate with W6/32, A1 .4, and 5511 antibodies . A, sequential precipitations . B, parallel precip-
itation . For complete absorption, each preclearing step with W6/32 or A1 .4 antibody was
performed three times. Only first (lanes 1 and 3) and last (lanes 2 and 4) absorptions are
shown . Each immunoprecipitate wasdone with an equal amount of the original SU cell lysate .
FIGURE 6 .
￿
Immunoblotting: AI .4 antibody reactivity with SDS-denaturedHLA heavy chains
from different T cell leukemias. SU and FF leukemia (5) cell lysates were prepared and
separated on SDS-PAGE as described in Materials and Methods . Nitrocellulose blots were
reacted with A1 .4 (lanes 1 and 3) or with an anti-HLA antibody recognizing an SDS-sensitive
antigenic determinant (lane 2), followed by reaction with radioiodinated goat anti-mouse IgG .
that A1 .4 binds to the SDS-denatured HLA heavy chain. A similar result was
observed with lysates from two differentT cell leukemias : SU cells (Fig . 6, lane
1), which express the 38 kD molecule coprecipitated by AIA, and FF cells (lane
3), which do not express this molecule . Thus, the antigenic determinant recog-
nized by A1 .4 is located on a nonpolymorphic regions of the typical 0zm-BUSHKIN ET AL.
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associated HLA heavy chain and the 02m-free HLA. It is not present on the 38
kD molecule coprecipitated by A1 .4 from SU and PR cell lysates (Figs. 1 and 2).
These results favor a noncovalent association of the /12m-free HLA and the 38
kD molecule, rather than sharing of an antigenic determinant by both chains.
Structural Similarity Between the a/# T Cell Receptor and the HLA/38 kD Hetero-
dimer Expressed on the Same Cells, as Shown by Chymotryptic Peptide Map-
ping. Although sequential immunoprecipitation experiments suggested that the
a/a T cell receptor and the HLA/38 kD heterodimer expressed on the same SU
leukemia cells are distinct molecules, chymotryptic peptide mapping experiments
revealed some similarities. The 38 and 43 kD chains immunoprecipitated from
precleared lysates and analyzed by SDS-PAGE in the sequential precipitation
experiment (Fig. 5, lanes 1, 3, and 5) were excised from the gel and subjected to
peptide mapping. As shown in Fig. 7, the 38 kD chain precipitated by A1.4 and
the 38 kD 0 chain of the T cell receptor precipitated by S511 shared 50% of
tyrosine-containing peptides, although some of the peptides on these maps were
unique for each molecule. Likewise, the comparison of peptide maps of the 02m-
free 43 kD chain precipitated by AI.4 and the 43 kD a chain of the T cell
receptor, precipitated by S511, revealed similarity but not identity between these
molecules (Fig. 8, B and C).
Of special interest was the comparison between peptide maps of the HLA
heavy chain precipitated by W6/32 and the 02m-free 43 kD chain precipitated
by A1 .4 from the cell lysate depleted of 02m-associated HLA (Fig. 8, A and B).
The salient finding was that the peptide map of the 43 kD chain precipitated by
A1.4 clearly contained four peptides not present in the peptide map of the HLA
heavy chain precipitated by W6/32. These additional peptides were found in
spite of preclearing the lysate with W6/32. At present, it is not clear whether
this difference is due to the fact that the 02m-free HLA heavy chair. may be
more accessible to the label than its 02M-associated counterpart, or to the fact
that the 02m-free 43 kD chain actually represents an HLA-like chain, distinct
from HLA heavy chain at the amino acid level. Generation of mAbs specific for
the 38 kD and 02M-free 43 kD chains precipitated by AI .4 antibody may help to
answer these questions.
Both the a/l3 T Cell Receptor and the 38 kD Chain Are Associated with the T3
Molecular Complex on the Surface of SU Leukemia Cells. Structural similarity
between the 38 kD molecule and the ,Q chain of T cell antigen receptor from the
same SU cells have prompted us to investigate whether this 38 kD molecule
could be comodulated with the T3 molecular complex similarly to comodulation
of T3 with the a/a T cell receptor (7, 32, 46). As seen in Fig. 9A, the Leu-4
mAb precipitated from the unmodulated radioiodinated SU leukemia cell lysate
the T3 molecular complex, consisting of three bands of 28, 24, and 22 kD,
respectively (lane 1). The 5511 mAb precipitated from the same lysate the 38/
43 kD a/o T cell receptor molecule (Fig. 9, lane 2). The AI.4 antibody
immunoprecipitated HLA heavy chain and 02m (as did W6/32 [Fig. 9, lane 3]),
and also coprecipitated the 38 kD chain (lane 4). As shown in Fig. 9B, partial
modulation of the T3 molecular complex from the surface of SU cells with Leu-
4 antibody, followed by radioiodination, immunoprecipitation, and SDS-PAGE
resulted in the loss of both the 38 kD molecule coprecipitated by A1 .4 antibody466
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FIGURE 7.
￿
Comparison among "5I-chymotryptic digests of the 38 kD chain and the ,Q chain
of theT cell receptor precipitated by A 1 .4 andS51 I antibodies . Molecules were isolated from
the W6/32-precleared lysate and separated on a slab gel as shown in Fig . 5 . Chymotryptic
digests were analyzed on thin-layer cellulose plates by electrophoresis in the first dimension
and chromatography in the second dimension . A, peptide map of the 38 kD chain coprecipi-
tated by A1 .4 antibody (from Fig . 5, lane 3) ; B, peptide map of the S chain of the a/oT cell
receptor precipitated by S51 I antibody (from Fig . 5, lane 5) ; C, mixture ofA andB. Tyrosine-
containing peptides common for both chains are designated by arrows.
and the 22-24kD light chains of T3 (lanes 2 and 4) . However, the 28 kD heavy
chain of T3, as well as the a and /3 chains of the T cell antigen receptor were
not modulated from the cell surface, and remained accessible to radioiodination
(Fig. 9B, lanes 3 and 4) under these conditions . A recent report (26) shows that
the ,Q chain of the human T cell antigen receptor is predominantly associated
with the 28 kD heavy chain of T3 molecular complex on the cell surface .
Accordingly, complete modulation of T3 from the surface of SU cells resultedBUSHKIN ET AL .
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FIGURE 8.
￿
Comparison among '2.I-chymotryptic digests of the 43 kD chains precipitated by
W6/32, A1 .4, and5511 antibodies . The 43 kD molecules were isolated from the slab gel (Fig .
5), digested with chymotrypsin, and analyzed as described in Fig . 7 . A-C, peptide maps of:
HLA heavy chain precipitated byW6/32 antibody (from Fig . 5, lane 1), ,82m-free HLA heavy
chain precipitated by AIA antibody (from Fig . 5, lane 3), and a chain of the a/,B T cell
receptor precipitated by S511 antibody (from Fig . 5, lane 5) . Tyrosine-labeled peptides present
in the,82m-free 43 kD chain precipitated byA 1 .4 antibody and absent in the HLAheavy chain
precipitated by W6/32 antibody are designated by long arrows . Peptides designated by stemless
arrows are common to the ,82m-free 43 kD chain precipitated by A1 .4 antibody and the a
chain of the a/#T cell receptor.
in comodulation of the a/(3 T cell receptor with the remaining 28 kD heavy
chain of T3 (Fig . 9C, lanes 1 and 2) .
The cytofluorographic analysis carried out parallel to radioiodination and
SDS-PAGE experiments was in accordance with the biochemical data in the sense468
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FIGURE 9 .
￿
Comodulation of the a/,6 T cell receptor and the 38 kD molecule with the T3
molecular complex on the surface ofSU leukemia cells .A shows immunoprecipitates obtained
from unmodulated radioiodinated SU leukemia cell lysate. Lanes 1-4 : labeled cell lysates
reacted with Leu-4, 5511, W6/32, and A1 .4 antibodies, respectively . Arrow designations :
triangle bracket for the 22-24 kD chains o£ T3 molecular complex, open stemless arrow for
the 28 kD chain of T3, blackened arrow for the 38 kD (0) chain of T cell receptor, and
blackened stemless arrow for the 38 kD chain coprecipitated by A1 .4 antibody . B shows
immunoprecipitates from partially modulated SU cells . Lanes 1-5 : W6/32, A1.4, S511, Leu-
4, and beads alone . C shows immunoprecipitates from completely modulated SU cells . Lanes
1-4 : Leu-4, S511, W6/32, and A1 .4 .
that leukemia cells completely modulated with Leu-4 antibody were totally
negative for Leu-4 and S511 immunofluorescence staining (not shown) .
Discussion
The results presented in this paper clearly indicate that at least some T cell
clones, represented by humanT cell leukemias such as SU, synthesize a 38 kD
glycoprotein that is similar but not identical to the ,Q chain of the classical a//3
38/43 kD T cell antigen receptor . The 38 kD molecule coexists with the a/,oT
cell receptor on the same cell, since generation of two different clonotypic
antibodies to SU cells (32) has confirmed the clonal nature of this leukemia .
Similarity between the (3 chain of theT cell receptor and the 38 kD molecule
was shown by endo-F digestion, 2D (IEF-SDS-PAGE) electrophoresis, and most
significantly, chymotryptic peptide mapping using precleared lysates (Figs . 3, 4,
and 7) . The latter method revealed that -50% of peptides are shared between
the two chains . Nevertheless, these two glycoproteins are distinct molecules, as
was clearly evidenced by sequential immunoprecipitation experiments and the
chymotryptic peptide maps (Figs . 5 and 7) . Several observations suggest that the
38 kD, HLA-associated chain coprecipitated by A1 .4 antibody does not have an
identical amino acid sequence to the a chain of the a/a T cell receptor : (a)
absence of the interchain disulfide bonds characteristic for the (3 chain of the T
cell antigen receptor ; (b) differences in peptide composition between the two
chains ; (c) sequential immunoprecipitation experiments showed a clear difference
between these two chains . However, comodulation experiments (discussed below)
have revealed that both the 38 kD HLA-associated chain and the 0 chain of theBUSHKIN ET AL.
￿
469
T cell receptor are associated with the T3 complex on the cell surface of SU
leukemia cells. Therefore, some biochemical and structural similarities between
these two distinct 38 kD chains allow us to hypothesize that both chains are
related.
Of special interest is the observed coprecipitation of the 38 kD molecule with
a 02m-free HLA. Our interpretation that the 43 kD chain of the 38/43 kD
heterodimer precipitated by AIA antibody from SU leukemia cell lysates is a
,02m-free HLA heavy chain is based on the following observations: (a) this
antibody recognizes an SDS-stable framework determinant on the HLA heavy
chain, as evidenced by immunoblotting experiments (Fig. 6) ; (b) chymotryptic
peptide maps of the 43 kD chain precipitated by the A1 .4 antibody from SU cell
lysates, and maps of the 43 kD chain precipitated by the A1.4 antibody from SU
lysates depleted of the W6/32-reactive 43 kD chain are nearly identical (Fig. 8).
On these peptide maps, however, four weakly labeled peptides (out of 19) are
unique for the 43 kD chain precipitated by AIA antibody. The appearance of
these four peptides might be due to higher accessibility of the 02m-free HLA
heavy chain to the radioactive label, or alternatively, might indicate the presence
of a distinct HLA heavy chain-like molecule such as a human analog of thymus
leukemia (TL), for example. However, murine TL heavy chains are character-
istically associated with 02m (47). In addition, comparison of chymotryptic and
trypticpeptide maps ofmurine TL and H-2 molecules has revealed little similarity
in the composition of the peptides (37, 48). Thus the data presented herein
support the argument that the A1 .4-reactive 02m-free 43 kD chain is not a
human TL equivalent. Immunoblotting experiments revealed that the A1 .4
antibody recognizes a determinant of the SDS-denatured 43 kD chain and not
the associated 38 kD chain. This does not favor the interpretation that AIA
recognizes identical epitopes on HLA heavy chains and on an unrelated 38 kD
cell membrane molecule. An association of the 38 kD chain with the 02m-free
HLA heavy chain could be due to noncovalent hydrogen bonds similar to the
association of 02m and HLA heavy chain (reviewed in 49).
Coprecipitation of a 38 kD chain by A1 .4 is not a unique feature of SU
leukemia, since the same anti-HLA antibody precipitated a similar 38 kD chain
from another human T cell leukemia (PR). The 38 kD chain precipitated from
PR leukemia cell lysates has both pl and molecular mass slightly different from
that of the 38 kD chain expressed on SU leukemia cells (Y. Bushkin, unpublished
data). Coprecipitation by Al . 4 antibody was observed in 2 of 14 T cell leukemias
tested. It is important to determine what subset of normal T cells expresses this
new 38/43 kD heterodimer. While no such heterodimer is precipitated from
resting peripheral blood T cells, a very small amount of the 38 kD chain is
coprecipitated by AIA antibody from the cell lysates of alloactivated polyclonal
T cells (Y. Bushkin, N. Mohagheghpour, and E. G. Engleman, unpublished data).
A 38 kD polypeptide may be synthesized by a minor subpopulation of these
alloactivated T cells. Thus the presence of the 38/43 kD heterodimer on the cell
surface may depend on the state of activation of the T cell.
The data presented in this paper show that the 38 kD molecule coprecipitated
by A1 .4 is associated with the T3 complex. Like the a/,o T cell receptor, it is
comodulated with the T3 complex, as shown in experiments that involved the470
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complete disappearance of the T3 complex from the membrane of SU cells
exposed to the Leu-4 antibody. In addition, examination of partially modulated
cells shows that the T3 complex may be dissociated, with disappearance of the
two smaller chains (22 and 24 kD) and persistence of the larger (28 kD)
component. We are presently investigating the precise conditions that determine
this partial modulation of the T3 complex and the role of accessory cells (40).
The dissociation of the 28 kD chain from the 22 and 24 kD components of the
T3 complex has been observed before (50) in normal human peripheral blood
T cells exposed to Leu-4 antibodies. When the cells exposed to Leu-4 lost the
smaller chains of T3 but retained the 28 kD chain, they also lost the 38 kD
molecule but retained their clonotypic Tcell receptor molecule. This observation
is consistent with the fact that the a/o T cell receptor is associated primarily with
the 28 kD chain of T3 (26), and supports the finding that the 38 kD molecule
and the clonotypic T cell antigen receptor are separate entities. These findings
suggest that, at least in SU cells, the T3 complex may serve as an aggregation
center of different molecules, since different components of the T3 complex
appear to react with the a/(0 T cell receptor and the 38/43 kD heterodimer.
In conclusion, the 38 kD chain expressed on the surface of SU leukemia cells
is noncovalently associated with 02m-free HLA as detected by mAb AIA. This
38 kD chain has significant structural homology to the a chain of the clonotypic
T cell receptor expressed on the same cells. Nevertheless, the 38 kD chain is a
distinct molecule. Its association with the T3 molecular complex suggests a
functional role in T cell activation. One possible interpretation is that this 38 kD
chain represents the still unidentified protein product of the -y-chain gene, or of
yet another member of the T cell receptor gene family. Currently we are
investigating the possibility that these 38 kD, HLA-associated chains from SU
and PR leukemia cells contain both constant and variable peptides similar to the
a and # chains of the classical T cell antigen receptor (51, 52).
Summary
The 38 kD molecule is noncovalently associated with 02 microglobulin (02m)-
free HLA heavy chain-like molecule, and thus forms a second heterodimer
distinct from the clonotypic a/,d T cell receptor expressed by the same clone of
leukemia cells. This second heterodimer (38 kD/HLA) is variably expressed and
appears to be associated with the T3 molecule. We suggest, therefore, that it has
a functional role in T cell activation.
Receivedfor publication 30 December 1985
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